Financials VIA Labs, Inc.

Equities

6756

TW0006756000

Semiconductors

End-of-day quote Taiwan S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
196.5 TWD +2.08% Intraday chart for VIA Labs, Inc. +3.69% -28.55%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization 1 14,280 33,818 12,400 18,995 13,631
Enterprise Value (EV) 1 14,280 33,818 12,400 18,995 13,631
P/E ratio 47.2 x - - - -
Yield - - - - -
Capitalization / Revenue 7.25 x 10 x 4.2 x 9.33 x 6.01 x
EV / Revenue 7.25 x 10 x 4.2 x 9.33 x 6.01 x
EV / EBITDA - 30,788,441 x - - -
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - - 3.9 x 6.65 x -
Nbr of stocks (in thousands) 60,000 67,500 68,511 69,074 69,371
Reference price 2 238.0 501.0 181.0 275.0 196.5
Announcement Date 3/21/21 3/8/22 3/9/23 3/14/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024
Net sales 1 1,970 3,367 2,955 2,035 2,267
EBITDA - 1,098 - - -
EBIT 1 - 1,030 709.6 156.1 232
Operating Margin - 30.58% 24.01% 7.67% 10.23%
Earnings before Tax (EBT) - - - - -
Net income - - - - -
Net margin - - - - -
EPS 5.040 - - - -
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/21/21 3/8/22 3/9/23 3/14/24 -
1TWD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 887.1 946 984.9 - 483.1 374 591.8 557.6 511.7 509 552 614 593
EBITDA - - - - - - - - - - - - -
EBIT 1 283 281.4 292.4 - 50.47 4.226 69.14 56.3 26.48 46 51 68 67
Operating Margin 31.9% 29.75% 29.69% - 10.45% 1.13% 11.68% 10.1% 5.17% 9.04% 9.24% 11.07% 11.3%
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - - - 137.5 - 15.05 - - - - - - -
Net margin - - - - - 4.02% - - - - - - -
EPS - - - 1.940 - 0.2100 - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/4/21 3/8/22 5/3/22 11/2/22 3/9/23 5/11/23 8/10/23 11/9/23 3/14/24 - - - -
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 30.3% - - -
ROA (Net income/ Total Assets) - 24.7% - - -
Assets - - - - -
Book Value Per Share - - 46.40 41.30 -
Cash Flow per Share - - - - -
Capex - 43.1 - - -
Capex / Sales - 1.28% - - -
Announcement Date 3/21/21 3/8/22 3/9/23 3/14/24 -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
196.5
Average target price
-
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6756 Stock
  4. Financials VIA Labs, Inc.